Main results
There were no included trials.
Authors' conclusions
There is no evidence from randomised controlled trials, upon which to base any practice recommendations regarding planned caesarean section for non-medical reasons at term. In the absence of trial data, there is an urgent need for a systematic review of observational studies and a synthesis of qualitative data to better assess the short-and long-term effects of caesarean section and vaginal birth.
P L A I N L A N G U A G E S U M M A R Y

Caesarean section for non-medical reasons at term
Childbirth is a profound and powerful human experience. Women often describe feelings of empowerment, elation and achievement, although other women's experiences include trauma, fear, pain, and loss of control. The way women give birth, either vaginally or by caesarean section, is likely to impact on their feelings. In recent years, caesareans have become safer due to improved anaesthesia and improved surgical techniques, along with the routine use of drugs at surgery to combat the increased risk of infection and blood clots in the mother. However, caesarean section remains a surgical procedure accompanied by abdominal and uterine incisions, scarring and adhesions. There is also evidence of an increased chance of problems in subsequent pregnancies for both women and babies.
This review found no trials to help assess the risks and benefits of caesarean section when undertaken without a conventional medical indication. The authors strongly recommend the use of alternative research methods to gather data on the outcomes associated with different ways of giving birth.
B A C K G R O U N D Description of the condition
Childbirth is a profound and powerful human experience. Women's accounts of birth often describe feelings of empowerment, elation and achievement, particularly following vaginal birth without medical interventions (Gaskin 2003) ; whereas other women associate childbirth with trauma, loss of control, fear, pain and anxiety. It is possible that the experience of giving birth may contribute to a woman's ability to adapt to parenthood, although there is only indirect evidence of this. Women giving birth in a supportive environment have been shown to have greater self-esteem, confidence in themselves as mothers, more positive child-rearing practices and less anxiety and depression after birth (Wolman 1993) .
Description of the intervention
The term 'caesarean section' refers to the operation of delivering a baby through incisions made in the mother's abdominal wall and uterus. Performed for certain medical indications such as placenta praevia (placenta lying over the opening of the cervix) or transverse lie (the baby lying across the uterus), caesarean section can be a life-saving operation (Neilson 2003) . A caesarean section is medically indicated when a significant risk of adverse outcome for mother or baby is present if the operation is not performed at a given time (Penna 2003) . However, the use of caesarean section for more vague medical indications (failure to progress, presumed fetal compromise) and non-medical reasons (for example, maternal request) is increasing in many resource-rich health services. Non-medically indicated caesarean sections may be performed for reasons other than the risk of adverse outcome if the person(s) assessing risk feel it is outweighed by the physical or psychological benefits. It has been suggested, for example, that a proportion of women, who request caesarean section for no apparent medical reason, may actually have been influenced by previous or current psychological trauma (Ryding 1993 ) such as sexual abuse or a previous traumatic birth. These may legitimately be regarded as clinical indications. In the UK, caesarean section accounted for 2% of all births in 1953, 18% in 1997 (Macfarlane 2000) and 21% in 2001 (Thomas 2001) . In 2010, the caesarean section rate (CSR) for England was 24.8% (ICHSC 2010 -Martin 2002) . Furthermore, marked differences are reported in rates from different healthcare sectors. During a two-year period in an urban area of India, total CSRs in the public, charitable and private sectors were 20%, 38% and 47% respectively (Sreevidya 2003) . The authors of this study speculate that physician convenience, preferences and financial incentives (for individuals and healthcare organisations) contribute to high CSRs in the private sector, and suggest that such factors may be important in other healthcare settings. The extent to which women's request for caesarean section for non-medical reasons has contributed to these rates, and why, is a contentious issue (Goer 2001; Karlstrom 2011; Kingdon 2009; Lowdon 2002; McAleese 2000; . Existing evidence from both retrospective and prospective studies is limited, utilising different definitions of 'maternal request', and reporting rates of between 1% and 48% in public sector healthcare systems, and 60% in the private sector (Declerq 2002; Thomas 2001) . There is insufficient understanding as to why women may request a caesarean section in the absence of a medical reason. Systematic literature reviews have highlighted specific methodological and conceptual issues with existing studies (Gamble 2000; as well as identifying personal and cultural reasons for maternal request (Gamble 2007; Kingdon 2006) . Moreover, a systematic review and meta-analysis of 38 observational studies reports a higher preference for caesarean section in women with a previous caesarean section versus women without a previous caesarean section (29.4%; 95% confidence interval (CI) 24.4 to 34.8 versus 10.1%; 95% CI 7.5 to 13.1 respectively) (Mazzoni 2011 ). Women's previous birth experience, fear of vaginal birth, need for choice and control, coupled with the cultural acceptability of caesarean section may all influence women's decision-making surrounding ways of giving birth. Whilst it is likely that the role of the caregiver in data generation, timing of data collection, women's post-hoc rationalisation and recall bias, have led to the over-reporting of maternal request for caesarean section, nonetheless, a percentage of women are now undergoing caesarean section for non-medical reasons. Informed decision-making for both clinicians and women is dependent on accurate information about the consequences of caesarean section compared with vaginal birth. In countries where the CSR is rising, the incidence of vaginal birth is, as expected, in decline. Intervention in the physiological processes of 'normal' birth varies according to birth setting. In high intervention birth settings where the use of artificial oxytocin, electronic fetal monitoring, epidural analgesia, artificially ruptured membranes, and instrumental deliveries are common, the extent to which adverse outcomes attributed to vaginal birth may also be associated with current obstetric management is an issue. The use of forceps may be particularly relevant to the debate on the possible maternal benefits of caesarean delivery increasingly being cited as including the protection of the pelvic floor to avoid perineal pain, dyspareunia, uterovaginal prolapse and incontinence of urine, flatus and/or faeces (Farrell 2001; Rortveit 2003; Sultan 1993; . Conversely, a large, 12-year, postpartum cohort study has reported caesarean section was not protective for urinary incontinence unless all the women's births were exclusively by caesarean section. Moreover, even after women having exclusively caesarean sections, the prevalence of urinary incontinence was high at 40% (MacArthur 2011). Other possible benefits of elective caesarean section discussed in both the professional and lay press include the convenience of scheduling the time and date of birth (Kirby 1999; . The extent to which convenience is cited as a maternal benefit may be confounded by the convenience for caregivers. The opportunity to schedule caesarean sections enables caregivers to plan staffing levels accordingly, performing the caesarean sections within daylight hours, and possibly reduce the incidence of litigation associated with vaginal birth or emergency caesareans (Birchard 1999) . Avoidance of pain during labour has also been cited as a potential maternal benefit of elective caesarean delivery (Turnbull 1999) ; as has the avoidance of emergency caesarean sections during labour, which has been associated with increases in morbidity and mortality (Lilford 1990; . Precise assessments of the mortality risks associated with elective caesarean section for non-medical reasons are problematic due to multiple definitions of 'elective', and a lack of up-to-date data which distinguishes between outcomes from scheduled or emergency caesarean sections. Nevertheless, Hall and Bewley (Hall 1999) have calculated the case-fatality rate for elective caesarean section in the UK during 1994 to 1996 and estimate it to be almost three times as great as that for vaginal births. The benefit-risk calculus associated with surgery has evolved, as techniques for surgery, anaesthesia, infection control, and blood banking have improved (Minkoff 2003) . Nonetheless, there is evidence to suggest increased maternal risks associated with the surgery, including anaesthetic risks, surgical complications, increased blood loss, need for transfusion, and pulmonary embolism (Kelleher 1994) . There may also be restricted activities of daily living (Chippington 2004), breastfeeding difficulties (Francome 1993) and increased maternal problems related to the uterine scar in subsequent pregnancies (Hemminki 1996) . A retrospective cohort study of 308,755 Canadian women who had experienced a previous caesarean section found trial of labour is associated with increased risk of uterine rupture (0.65% in the trial of labour group compared with 0.25% in the non-trial of labour group), but elective caesarean section may increase the risk of maternal death (1.6 per 100,000 in the trial of labour group compared with 5.6 per 100,000 in the elective caesarean section group (Wen 2004) . Furthermore new, unexpected long-term risks of caesarean section continue to be reported; these include abnormal placentation (Serena 2005) , ectopic pregnancy, haemorrhage and hysterectomy following uterine evacuation, latex allergy, implantation endometriosis, adenomyosis and increased hospital readmission (Bewley 2002) . Caesarean section has also been associated with emotional difficulties (Clement 2001) including postpartum depression and negative feelings about the experience of childbirth, but not specifically among women undergoing caesarean delivery by choice (Minkoff 2003) . Suggested increased risks for the baby of delivery by caesarean section include, increased admission to neonatal units/separation of the mother and neonate (Treffers 1993) , iatrogenic prematurity , laceration (Smith 1997) , increased neonatal respiratory problems (Madar 1999) , increased special educational needs in later life linked to the timing of the caesarean section (Kapellou 2011; MacKay 2010) and stillbirth in the next pregnancy . A recent literature review suggests that vaginal births involve important physiological changes that are absent or modified in babies born by caesarean section (Hyde 2011). Authors suggest that vaginal birth is an important life programming event for the infant, and that the differences in physiology that arise between vaginal and caesarean births have implications for the infant, with caesarean section increasing the risk of compromised health in both the short and the long term (Hyde 2011). In a large multi-centre randomised controlled trial of planned caesarean section versus planned vaginal birth for breech presentation, at three months postnatally, women in the planned caesarean delivery group were less likely to report urinary incontinence (Hannah 2002) . There was no statistically significant difference regarding incontinence of flatus between groups, but more women reported that it was less of a problem in the planned caesarean delivery group. At three months there were no differences between groups in breastfeeding; infant health; ease of caring for infant and adjusting to being a new mother; sexual relations; pain; depression; and views regarding childbirth experience. The trial reported a significant reduction in adverse perinatal outcomes without an increased risk of immediate maternal morbidity with planned caesarean section compared with planned vaginal birth. The two-year follow up of the same trial (Hannah 2004) showed no differences between groups in breastfeeding; relationship with child or partner; pain; subsequent pregnancy; incontinence; depression; urinary, menstrual or sexual problems; fatigue; or distressing memories of the birth experience. Planned caesarean section was associated with a higher risk of constipation. There was no difference identified between planned caesarean section and planned vaginal birth in risk of death or neurodevelopmental delay in children at two years of age (Whyte 2004 ). This finding was surprising, given the reduction in the risk of perinatal or neonatal death, or serious neonatal morbidity, with a policy of planned caesarean birth found at three months. The applicability of these findings for cephalic presentation is debatable. Maternal and neonatal physical health outcomes must also be considered alongside psychosocial influences and the wider cultural context. For example, the trend towards smaller families may be relevant when considering the risks of caesarean section for subsequent pregnancies. The increasingly cited risks of vaginal birth such as placental abruption, cord prolapse, undiagnosed fetal hypoxaemia and shoulder dystocia (Paterson-Brown 1997) must be considered in the context of the medical model within technologydependent cultures where intervention in the natural processes of reproduction is common. For many healthcare systems, the economic costs associated with different modes of delivery are as pertinent as the social costs. A recent economic model, developed to determine the cost consequence of planned caesarean section in the absence of medical indication to the NHS, estimated it to range from £10.9 to £14.8 million per annum. The mean cost saving of switching from a planned caesarean section to a planned vaginal birth was £1257 per birth (NCCWCH 2004) . However, in the USA it would appear the costs of increased intervention in vaginal deliveries, the addition of oxytocin specifically, can nullify any cost differences between delivery mode. If epidural anaesthesia is also used, total costs exceeded the cost of elective caesarean delivery by almost 10% in one study (Bost 2003) . This review is one of a series of Cochrane reviews on planned caesarean section; other reviews focus on elective caesarean section for medical indications ('Planned caesarean section for term breech delivery' (Hofmeyr 2003), 'Planned elective repeat caesarean section versus planned vaginal birth for women with a previous caesarean birth' (Dodd 2004), 'Planned caesarean section for multiple pregnancy' (Dodd 2002).
Why it is important to do this review
Caesarean section for non-medical reasons is a multifaceted complex issue, the implications of which for childbearing women, healthcare professionals and society are unknown. For women, requesting a caesarean section for non-medical reasons is an emotive and very personal decision. For clinicians, performing a caesarean section for non-medical reasons is a professional decision, the ethics of which are being debated without sufficient evidence of the risks, as well as the benefits. The review aims to assist women and clinicians to make informed evidence-based decisions about the way women give birth.
O B J E C T I V E S
To assess, from randomised trials, the effects on perinatal and maternal morbidity and mortality, and on maternal psychological morbidity, of planned caesarean delivery versus planned vaginal birth where there is no clear clinical indication for a caesarean section.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All comparisons of intention to perform caesarean section and intention to give birth vaginally; random allocation to treatment and control groups; violations of allocated management and exclusions after allocation not sufficient to materially affect outcomes. Given the nature of the review objective, we planned to include observational and qualitative research in the discussion, to place any trial findings in a social, cultural, organisational, and geographical context.
Types of participants
Pregnant women, singleton pregnancy, cephalic presentation at term, with no conventional medical indication for caesarean section.
Types of interventions
Planned caesarean section compared with planned vaginal birth in the absence of a medical reason for caesarean section (non-medical reason as defined by trial authors).
Types of outcome measures
Primary outcomes 1. Serious maternal morbidity or death (e.g. admission to intensive care unit, septicaemia, organ failure); 2. serious neonatal morbidity or perinatal death, excluding fatal malformations (e.g. seizures, birth asphyxia defined by trialists, neonatal encephalopathy);
3. maternal postnatal depression (as defined by trial authors).
Secondary outcomes
Short-term maternal outcomes 
Search methods for identification of studies Electronic searches
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register by contacting the Trials Search Co-ordinator (31 January 2012). The Cochrane Pregnancy and Childbirth Group's Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:
1. quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL); 2. weekly searches of MEDLINE; 3. weekly searches of EMBASE; 4. handsearches of 30 journals and the proceedings of major conferences; 5. weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. Details of the search strategies for CENTRAL, MEDLINE and EMBASE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the 'Specialized Register' section within the editorial information about the Cochrane Pregnancy and Childbirth Group. Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.
Searching other resources
We searched for further studies in the reference lists. We did not apply any language restrictions. For details of searching carried out for the initial version of the review, please see Appendix 1.
Data collection and analysis
The following methodology would have been applied had we identified any studies, and it will be used if studies are identified in future updates.
Selection of studies
Three review authors (Tina Lavender, Carol Kingdon and Gill Gyte) independently assessed for inclusion all the potential studies we identified as a result of the search strategy. There was agreement but had there been any disagreement this would have been resolved through discussion or, if required, we would have consulted our remaining review authors.
Data extraction and management
We designed a form to extract data. In future, for eligible studies, at least two review authors will extract the data using the agreed form. We will resolve discrepancies through discussion or, if required, we will consult a third person. We will enter data into Review Manager software (RevMan 2011) and check for accuracy. When information regarding any of the above is unclear, we will attempt to contact authors of the original reports to provide further details.
Assessment of risk of bias in included studies
Two review authors will independently assess risk of bias for each study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). We will resolve any disagreement by discussion or by involving a third assessor.
(1) Random sequence generation (checking for possible selection bias)
We will describe for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. We will assess the method as:
• low risk of bias (any truly random process, e.g. random number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);
• unclear risk of bias. We will describe for each included study the method used to conceal allocation to interventions prior to assignment and will assess whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.
We will assess the methods as:
• low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or nonopaque envelopes, alternation; date of birth);
• unclear risk of bias. It is not possible to blind either participants or personnel in these studies. We will consider the possible impact of this when interpreting the data for relevant outcomes. It will be possible to blind outcome assessors for some outcomes only. Where blinding is not possible, we will consider the possible impact of this when interpreting the data for relevant outcomes. We will describe for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We will state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information is reported, or can be supplied by the trial authors, we will re-include missing data in the analyses which we undertake. We will assess methods as:
• low risk of bias (e.g. 20% or less missing outcome data; missing outcome data balanced across groups);
• high risk of bias (e.g. greater than 20% missing data; missing data imbalanced across groups; 'as treated' analysis done with substantial departure of intervention received from that assigned at randomisation);
• unclear risk of bias. We will describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found. We will assess the methods as:
• low risk of bias (where it is clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review have been reported);
• high risk of bias (where not all the study's pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)
We will describe for each included study any important concerns we have about other possible sources of bias. We will assess whether each study was free of other problems that could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
(7) Overall risk of bias
We will make explicit judgements about whether studies are at high risk of bias, according to the criteria given in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). With reference to (1) to (6) above, we will assess the likely magnitude and direction of the bias and whether we consider it is likely to impact on the findings. We will explore the impact of the level of bias through undertaking sensitivity analyses -see Sensitivity analysis.
Measures of treatment effect Dichotomous data
For dichotomous data, we will present results as summary risk ratio with 95% confidence intervals.
Continuous data
For continuous data, we will use the mean difference if outcomes are measured in the same way between trials. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods.
Unit of analysis issues
We do not anticipate any cluster-or cross-over trials as we believe these methodologies are unsuitable for our review question.
Dealing with missing data
For included studies, we will note levels of attrition. We will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. For all outcomes, we will carry out analyses, as far as possible, on an intention-to-treat basis, i.e. we will attempt to include all participants randomised to each group in the analyses, and all participants will be analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial will be the number randomised minus any participants whose outcomes are known to be missing.
Assessment of heterogeneity
We will assess statistical heterogeneity in each meta-analysis using the T², I² and Chi² statistics. We will regard heterogeneity as substantial if I² is greater than 30% and either T² is greater than zero, or there is a low P value (less than 0.10) in the Chi² test for heterogeneity.
Assessment of reporting biases
If there are 10 or more studies in the meta-analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually, and use formal tests for funnel plot asymmetry. For continuous outcomes, we will use the test proposed by Egger 1997, and for dichotomous outcomes, we will use the test proposed by Harbord 2006. If asymmetry is detected in any of these tests, or is suggested by a visual assessment, we will perform exploratory analyses to investigate it.
Data synthesis
We will carry out statistical analysis using the Review Manager software (RevMan 2011). We will use fixed-effect meta-analysis for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are examining the same intervention, and the trials' populations and methods are judged sufficiently similar. If there is clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we will use random-effects meta-analysis to produce an overall summary if an average treatment effect across trials is considered clinically meaningful. The random-effects summary will be treated as the average range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not combine trials. If we use random-effects analyses, the results will be presented as the average treatment effect with 95% confidence intervals, and the estimates of T² and I².
Subgroup analysis and investigation of heterogeneity
If we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses. We will consider whether an overall summary is meaningful, and if it is, use random-effects analysis to produce it. We plan to carry out the following subgroup analyses on our primary outcomes only:
1. nulliparous and multiparous; 2. services with low (20 or less per 1000) and high perinatal mortality (more than 20); 3. natural conception and assisted conception; 4. low-level intervention in the first stage of labour in at least 75% versus less than 75% in the planned vaginal birth group; 5. low-level intervention in the first stage of labour, defined as spontaneous onset without regional anaesthesia -epidural, spinal or combination of the two (Birth Choice UK 2001). We will assess differences between subgroups by carrying out subgroup interaction tests available in RevMan 2011.
Sensitivity analysis
We will perform sensitivity analysis based on trial quality, separating high-quality trials from trials of lower quality. 'High quality' will, for the purposes of this sensitivity analysis, be defined as a trial having adequate sequence generation, allocation concealment and an attrition rate of less than 20%, given the stated importance of attrition as a quality measure ). We will carry out sensitivity analysis for primary outcomes only.
R E S U L T S Description of studies
See: Characteristics of excluded studies.
Results of the search
The search strategies yielded two studies for consideration of inclusion (see Characteristics of excluded studies).
Included studies
We found no studies for inclusion in this review.
Excluded studies
Neither of the studies met the basic inclusion criteria and were therefore excluded. One study (European Mode 1999) only included women with a confirmed diagnosis of HIV-1 infection, which is a medical, as opposed to a 'non-medical', indication for caesarean section. Furthermore, it is unclear from the data how many participants had singleton pregnancies, cephalic presentations, term babies or complications of pregnancy, as the decision to randomise was at the clinician's discretion. The remaining study (Pence 2002) was excluded because of the potential for selection bias; the demography and parity of the sample and method of randomisation was unclear. We attempted to contact the author of this paper, to clarify these issues, without success.
Risk of bias in included studies
No studies met the eligibility criteria for inclusion in this review.
Effects of interventions
D I S C U S S I O N
There are no randomised controlled trials of planned caesarean section versus planned vaginal birth for non-medical reasons at term, which makes the comparability of the effects on perinatal and maternal morbidity and mortality, and maternal psychological morbidity, for these two different ways of giving birth problematic.
The need for evidence of the effects of caesarean section performed for non-medical reasons at term on perinatal and maternal mortality, and maternal psychological morbidity, is important to women and clinicians. The actual number of women requesting caesarean birth in the absence of clear indications for themselves or their baby is unknown (Klein 2004) . Furthermore, women's preferences for birth mode are likely to change as their pregnancies progress (Kingdon 2009). In Kingdon's study, only 2% of women expressed a preference for caesarean birth by late pregnancy. However, a proportion of women are currently undergoing caesarean section performed for non-medical reasons at term, whilst existing evidence concerning the risks and benefits is keenly contested by professionals (Minkoff 2003) and consumer organisations representing maternity service users (Lowdon 2002).
Informed decision-making surrounding vaginal or caesarean birth is considered by some to be aided in specific situations, where randomised controlled trials have been performed and systematically reviewed. For example, planned caesarean section for term breech delivery (Hofmeyr 2003) , or planned elective repeat caesarean section versus planned vaginal birth for women with a previous caesarean birth (Dodd 2004).
The findings of existing trials of planned caesarean section performed for medical indications versus planned vaginal birth are not applicable to situations where there are no medical reasons, because caesarean mortality and morbidity is confounded by preexisting obstetric or general medical conditions (that is, European Mode 1999). The use of data from observational studies of planned caesarean for non-medical reason and planned vaginal birth seems at present inconclusive. For example, in the UK, the most recent data suggest that the estimated case fatality rate per million maternities and risk ratio for elective caesarean section were twice that for vaginal birth. However, this was not statistically significant and "it cannot be concluded that caesarean section is necessarily more dangerous than vaginal birth" (Hall 2001); particularly as the number of elective caesarean sections performed for medical indications was unclear.
The extent to which performing a randomised controlled trial of planned caesarean section for non-medical reasons versus planned vaginal birth would provide sufficient evidence to assess the risks and benefits of all relevant outcomes is debatable (McCourt 2004) . Furthermore, to discuss the possibility of such a trial not only raises important methodological questions, but also introduces significant moral concerns about the ethics of undertaking a trial where women randomised to the intervention arm would receive surgery in the absence of a medical indication. Such issues have been raised by health professionals (Lavender 2005) and women (Lavender 2009), in the UK.
A U T H O R S ' C O N C L U S I O N S Implications for practice
There is no evidence from randomised controlled trials upon which to base any practice recommendations regarding planned caesarean section for non-medical reasons at term.
Implications for research
Although a number of trials have assessed the efficacy of planned vaginal birth versus planned caesarean section, sample populations have included women with potential (Barrett 2004; Dodd 2004; Hannah 2000) or actual pregnancy complications (European Mode 1999). Planned caesarean section for non-medical reasons at term is more contentious because it involves a surgical procedure where there is neither a medical problem nor any complications. The lack of existing evidence is likely to be due to the lack of equipoise for such a trial or the highly complex methodological issues which such a trial may generate (Lavender 2005) . These include the complexity of following up women throughout their reproductive life; the difficulty of agreeing on a single primary outcome on which to base sample-size calculations; and the prohibitive cost of a trial in relation to more pertinent research questions. The routine collection of good quality prospective morbidity data (short and long term) may provide the best available evidence from which women can make informed decisions. Qual-
